Earnings History Data for Marinus Pharmaceuticals, Inc. (MRNS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on developing and commercializing therapeutics for the treatment of epilepsy and other targeted neurological, behavioral and psychiatric disorders. The Company offers Ganaxolone which has completed Phase II clinical trial for the treatment of patients with refractory focal onset seizures. Marinus Pharmaceuticals, Inc. is headquartered in New Haven, Connecticut.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
11-08-2022 PM 7:15 AM ET
(Aug 11)
MRNS Marinus Pharmaceuticals, Inc. 218.01 -1.06 -0.93 -0.65 Marinus Pharmaceuticals GAAP EPS of -$1.06 misses by $0.37, revenue of $1.8M misses by $0.51M
[8/11/2022 7:34 AM]
5.72 -0.21 
(-3.54%)
5.90 -0.03 
(-0.51%)
3.97 - 13.15 148,030 220,000 5,263
12-05-2022 AH 4:00 PM ET
(May 12)
MRNS Marinus Pharmaceuticals, Inc. 189.17 -0.52 -0.87 -0.74 Marinus Pharmaceuticals GAAP EPS of -$0.52 beats by $0.33, revenue of $14.19M beats by $11.91M
[5/12/2022 4:18 PM]
5.69 0.83 
(17.08%)
4.92 0.06 
(1.23%)
4.19 - 19.83 222,307 280,000 225
21-03-2022 PM 7:00 AM ET
(Mar 21)
MRNS Marinus Pharmaceuticals, Inc. 315.82 -0.77 -0.81 -0.55 Marinus Pharmaceuticals GAAP EPS of -$0.77 misses by $0.02, revenue of $1.52M misses by $1.98M
[3/21/2022 7:18 AM]
8.71 -1.29 
(-12.90%)
9.10 -0.90 
(-9.00%)
7.16 - 19.83 1,065,644 310,158 91,605
09-11-2021 PM 7:00 AM ET
(Nov 9)
MRNS Marinus Pharmaceuticals, Inc. 467.23 -0.53 -0.62 -0.51 Marinus Pharmaceuticals EPS beats by $0.12, beats on revenue
[11/9/2021 7:09 AM]
12.72 -0.09 
(-0.70%)
12.81 0.0 
(0.00%)
10.71 - 20.04 119,280 160,000 3,384
10-08-2021 PM 7:30 AM ET
(Aug 10)
MRNS Marinus Pharmaceuticals, Inc. 472.63 -0.65 -0.68 -0.64 Marinus Pharmaceuticals EPS beats by $0.04, misses on revenue
[8/10/2021 7:08 AM]
13.12 0.32 
(2.50%)
13.12 0.0 
(0.00%)
6.84 - 20.04 285,600 170,000 191
17-05-2021 PM 7:00 AM ET
(May 17)
MRNS Marinus Pharmaceuticals, Inc. 516.23 -0.74 -0.46 -1.28 Marinus Pharmaceuticals EPS misses by $0.29, misses on revenue; issues FY 2021 guidance
[5/17/2021 7:38 AM]
15.05 -1.13 
(-6.98%)
16.18 0.0 
(0.00%)
6.04 - 20.04 381,448 200,000 3,417
09-03-2021 PM 7:30 AM ET
(Mar 9)
MRNS Marinus Pharmaceuticals, Inc. 588.76 -0.55 -0.52 -1.04 Marinus Pharmaceuticals EPS misses by $0.05, beats on revenue
[3/9/2021 7:02 AM]
18.60 1.88 
(11.27%)
17.00 0.28 
(1.67%)
4.16 - 19.12 737,925 353,847 5,923
09-11-2020 AH 4:15 PM ET
(Nov 9)
MRNS Marinus Pharmaceuticals, Inc. 412.73 -0.51 -0.62 -1.04 Marinus Pharmaceuticals EPS beats by $0.09, misses on revenue
[11/9/2020 4:33 PM]
13.84 0.13 
(0.95%)
14.66 0.95 
(6.93%)
4.04 - 16.28 396,838 406,137 5,484